|
US6673779B2
(en)
|
1996-03-27 |
2004-01-06 |
Inspire Pharmaceuticals, Inc. |
Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues
|
|
US6319908B1
(en)
|
1996-07-03 |
2001-11-20 |
Inspire Pharmaceuticals, Inc. |
Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
|
|
US5763447C1
(en)
|
1996-07-23 |
2002-05-07 |
Inspire Pharmaceuticals |
Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
|
|
DK0981534T3
(da)
|
1997-02-06 |
2006-09-04 |
Inspire Pharmaceuticals Inc |
Dinukleotider og deres anvendelser
|
|
US7078391B2
(en)
*
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
|
US6818629B2
(en)
*
|
1997-02-10 |
2004-11-16 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
|
|
US7223744B2
(en)
*
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
|
US6596725B2
(en)
|
1997-02-10 |
2003-07-22 |
Inspire Pharmaceuticals, Inc. |
Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
|
|
US6462028B2
(en)
|
1997-07-25 |
2002-10-08 |
Inspire Pharmaceuticals, Inc. |
Method of promoting cervical and vaginal secretions
|
|
US6872710B2
(en)
*
|
1997-07-25 |
2005-03-29 |
Inspire Pharmaceuticals, Inc. |
Di(uridine 5′)-tetraphosphate and salts thereof
|
|
US6548658B2
(en)
*
|
1997-07-25 |
2003-04-15 |
Inspire Pharmaceuticals, Inc. |
Di-(uridine 5′)-tetraphosphate and salts thereof
|
|
TW593331B
(en)
|
1997-07-25 |
2004-06-21 |
Inspire Pharmaceuticals Inc |
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
|
|
DE69822482T2
(de)
*
|
1997-07-25 |
2005-03-03 |
Inspire Pharmaceuticals, Inc. |
Salze von di(uridine 5'-tetraphosphate), verfahren zur herstellung und verwendungen davon
|
|
EP1011688B1
(en)
*
|
1997-08-29 |
2005-02-02 |
The University of North Carolina at Chapel Hill |
Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
|
|
ATE232733T1
(de)
*
|
1998-05-22 |
2003-03-15 |
Inspire Pharmaceuticals Inc |
Therapeutische dinucleotide und deren derivate
|
|
JP2002533110A
(ja)
*
|
1998-12-23 |
2002-10-08 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
Ｇタンパク質共役レセプターを使用した目的とする遺伝子の導入
|
|
BR0008498A
(pt)
|
1999-02-26 |
2002-02-05 |
Inspire Pharmaceuticals Inc |
Método de promoção de hidratação de mucosas com certos difosfatos de uridina, adenina e citidina e seus análogos
|
|
DE60006814T2
(de)
|
1999-06-30 |
2004-05-19 |
Yamasa Corp., Choshi |
Dinucleotid-kristalle
|
|
AU6551800A
(en)
*
|
1999-08-17 |
2001-03-13 |
Adani, Alexander |
Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses
|
|
EP1261323A2
(en)
*
|
1999-12-22 |
2002-12-04 |
Inspire Pharmaceuticals, Inc. |
Method of treating gastrointestinal tract disease with purinergic receptor agonists
|
|
RU2161982C1
(ru)
*
|
2000-01-20 |
2001-01-20 |
Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии" |
Тетрапептид, стимулирующий функцию сетчатой оболочки глаза, фармакологическое средство на его основе и способ его применения
|
|
US6864243B1
(en)
*
|
2000-05-12 |
2005-03-08 |
Inspire Pharmaceuticals, Inc. |
Method for treating retinal degeneration with purinergic receptor agonists
|
|
BR0111297A
(pt)
*
|
2000-05-30 |
2004-01-06 |
Santen Pharmaceutical Co Ltd |
Promotor de migração epitelial corneana
|
|
US7115585B2
(en)
*
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
US6555675B2
(en)
*
|
2000-08-21 |
2003-04-29 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
|
|
US7132408B2
(en)
*
|
2000-08-21 |
2006-11-07 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US7452870B2
(en)
*
|
2000-08-21 |
2008-11-18 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with P2Y12 receptor antagonist compound
|
|
US6867199B2
(en)
|
2000-08-21 |
2005-03-15 |
Inspire Pharmaceuticals, Inc. |
Dinucleoside polyphosphate compositions and their therapeutic use
|
|
US7018985B1
(en)
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
|
US20040266723A1
(en)
*
|
2000-12-15 |
2004-12-30 |
Otto Michael J. |
Antiviral agents for treatment of Flaviviridae infections
|
|
EP1368366A1
(en)
*
|
2001-02-07 |
2003-12-10 |
Celltech R & D Limited |
Non-natural nucleotides and dinucleotides
|
|
AR034635A1
(es)
|
2001-06-25 |
2004-03-03 |
Inspire Pharmaceuticals Inc |
Lubricacion de las articulaciones con agonistas del receptor purinergico p2y
|
|
US20050009777A1
(en)
*
|
2001-07-25 |
2005-01-13 |
Mack Stephen Robert |
Non-natural carbon-linked nucleotides and dinucleotides
|
|
US20030109488A1
(en)
*
|
2001-10-11 |
2003-06-12 |
Alcon, Inc. |
Methods for treating dry eye
|
|
CN1612739A
(zh)
*
|
2001-11-06 |
2005-05-04 |
印斯拜尔药品股份有限公司 |
治疗或预防炎性疾病的方法
|
|
US7084128B2
(en)
*
|
2002-01-18 |
2006-08-01 |
Inspire Pharmaceuticals, Inc. |
Method for reducing intraocular pressure
|
|
JP2006505585A
(ja)
*
|
2002-10-18 |
2006-02-16 |
モリケム メディシンズ， インコーポレイテッド |
ランチビオティクスで眼乾燥症を処置する方法
|
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
|
WO2005107787A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Molichem Medicines, Inc. |
Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
|
|
US7479481B2
(en)
*
|
2004-05-06 |
2009-01-20 |
Molichem Medicines, Inc. |
Treatment of ocular diseases and disorders using lantibiotic compositions
|
|
GB0417886D0
(en)
*
|
2004-08-11 |
2004-09-15 |
Univ Cardiff |
Method and means for enhanced pulmonary delivery
|
|
GB0502250D0
(en)
*
|
2005-02-03 |
2005-03-09 |
Ic Vec Ltd |
Use
|
|
US7368439B2
(en)
*
|
2005-06-15 |
2008-05-06 |
Bar - Ilan University |
Dinucleoside poly(borano)phosphate derivatives and uses thereof
|
|
US7851456B2
(en)
*
|
2005-06-29 |
2010-12-14 |
Inspire Pharmaceuticals, Inc. |
P2Y6 receptor agonists for treating lung diseases
|
|
EP1959968A2
(en)
|
2005-12-06 |
2008-08-27 |
P2-Science APS |
Modulation of the p2y2 receptor pathway
|
|
US20070249556A1
(en)
*
|
2006-04-21 |
2007-10-25 |
Brubaker Kurt E |
Method of treating inflammation
|
|
EP2045257B1
(en)
*
|
2006-07-26 |
2016-08-17 |
Yamasa Corporation |
Process for producing di(pyrimidine nucleoside 5'-)polyphosphate
|
|
EP2049665A2
(en)
*
|
2006-07-28 |
2009-04-22 |
Applera Corporation |
Dinucleotide mrna cap analogs
|
|
AU2008310734B2
(en)
|
2007-10-10 |
2014-06-05 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
|
WO2010048341A1
(en)
*
|
2008-10-22 |
2010-04-29 |
Inspire Pharmaceuticals, Inc. |
Method for treating cystic fibrosis
|
|
US9067964B2
(en)
|
2008-12-18 |
2015-06-30 |
Oligomer Sciences Ab |
Complex and method for enhancing nuclear delivery
|
|
US9011909B2
(en)
|
2010-09-03 |
2015-04-21 |
Wisconsin Pharmacal Company, Llc |
Prebiotic suppositories
|
|
EP2614838B1
(en)
|
2010-09-10 |
2016-04-20 |
Santen Pharmaceutical Co., Ltd. |
Diquafosol and hyaluronic acid or salts thereof for the treatment of dry eye
|
|
CN103732213A
(zh)
|
2011-06-07 |
2014-04-16 |
帕里昂科学公司 |
治疗方法
|
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
ES2702575T3
(es)
|
2012-03-26 |
2019-03-04 |
Santen Pharmaceutical Co Ltd |
Solución oftálmica que comprende diquafosol
|
|
EP3366680B1
(en)
|
2012-05-29 |
2020-05-13 |
Parion Sciences, Inc. |
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
|
|
RU2015129065A
(ru)
|
2012-12-17 |
2017-01-25 |
Пэрион Сайенсиз, Инк. |
Производные хлор-пиразинкарбоксамида, обладающие активностью блокирования эпителиальных натриевых каналов
|
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
|
CN104995178B
(zh)
|
2012-12-17 |
2018-06-26 |
帕里昂科学公司 |
3，5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
|
|
WO2016014927A2
(en)
|
2014-07-24 |
2016-01-28 |
W.R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
|
CN107428791B
(zh)
|
2015-03-09 |
2024-05-28 |
格雷斯公司 |
烟酰胺核苷的结晶形式
|
|
US20180125876A1
(en)
|
2015-05-20 |
2018-05-10 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
|
|
WO2019126482A1
(en)
|
2017-12-22 |
2019-06-27 |
Elysium Health, Inc. |
Crystalline forms of nicotinamide riboside chloride
|
|
WO2021245107A2
(en)
|
2020-06-02 |
2021-12-09 |
Institut Gustave Roussy |
Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom
|
|
EP3919062A1
(en)
|
2020-06-02 |
2021-12-08 |
Institut Gustave-Roussy |
Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom
|